ArticleCancer research2022

Retinoic Acid Receptor Activation Reduces Metastatic Prostate Cancer Bone Lesions by Blocking the Endothelial-to-Osteoblast Transition.

Guoyu Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.